CLINICAL_TRIALS
trial_result
· 2015-03-09
Clinical Trial Update: Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) [Phase 3]
Summary
Extension study of asenapine in pediatric bipolar disorder (Phase 3) has completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-03-09